PLURI INC Reported Earnings

PLURI INC (PLUR) reported a loss of $0.54 per share on revenue of $0.34 million for the . . Revenue fell 63.15% compared to the same quarter a year ago.

Pluri Inc. is a biotechnology company. Its technology platform, a patented and validated state-of-the-art 3D cell expansion system, advances novel cell-based solutions for a range of medicine and climate change to food scarcity, animal cruelty and beyond. Pluri Inc., formerly known as Pluristem Therapeutics Inc., is based in HAIFA, Israel.